Lyrus Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 96.25 Cr
as on 17-11-2024
- Paid Up Capital ₹ 96.23 Cr
as on 17-11-2024
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 18.50 Cr
as on 17-11-2024
- Satisfied Charges ₹ 38.13 Cr
as on 17-11-2024
- Revenue -8.96%
(FY 2023)
- Profit -16.25%
(FY 2023)
- Ebitda -170.25%
(FY 2023)
- Net Worth -21.53%
(FY 2023)
- Total Assets 16.37%
(FY 2023)
About Lyrus Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 96.25 Cr and a paid-up capital of Rs 96.23 Cr.
The company currently has active open charges totaling ₹18.50 Cr. The company has closed loans amounting to ₹38.13 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Lyrus Life Sciences Private Limited India is Dasari Ramesh as COMPANY SECRETARY. Hemanth Bothra and Leela Kanwar serve as directors at the Company.
- CIN/LLPIN
U24230KA2015PTC080902
- Company No.
080902
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Jun 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Lyrus Life Sciences Private Limited offer?
Lyrus Life Sciences Private Limited offers a wide range of products and services, including Contract Employment & Staffing Firms, Manpower Service, Ayurvedic Powder and Medicinal Herbs, Medicinal Plant, Diagnostic Imaging & Pathology Labs, Medical Test Services, Research and Development (R&D) Work, Product Development Research, Herbs,Sticks and Roots, Pharma & Bioanalytical Services.
Who are the key members and board of directors at Lyrus Life Sciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hemanth Bothra  | Managing Director | 16-Jun-2015 | Current |
| Dasari Ramesh | Company Secretary | 20-Jun-2017 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Leela Kanwar | Director | 16-Jun-2015 | Current |
Financial Performance and Corporate Structure Insights of Lyrus Life Sciences.
Lyrus Life Sciences Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.96% decrease. The company also saw a substantial fall in profitability, with a 16.25% decrease in profit. The company's net worth observed a substantial decline by a decrease of 21.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lyrus Life Sciences?
In 2023, Lyrus Life Sciences had a promoter holding of 100.00%. The company had 1 Joint Venture. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Trust Chemists And Druggists Private LimitedActive 21 years 8 monthsHemanth Bothra and Leela Kanwar are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 28 Feb 2024 | ₹18.50 Cr | Open |
Canara Bank Creation Date: 04 Sep 2018 | ₹38.13 Cr | Satisfied |
How Many Employees Work at Lyrus Life Sciences?
Lyrus Life Sciences has a workforce of 104 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lyrus Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lyrus Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
